ANUPAM RASAYAN INDIA LTD.
NSE : ANURASBSE : 543275ISIN
CODE : INE930P01018Industry : ChemicalsHouse
: Private
BSE784.25-4.9 (-0.62 % )
PREV CLOSE (Rs.) 789.15
OPEN PRICE (Rs.) 793.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 1793
TODAY'S LOW / HIGH (Rs.)
52 WK LOW / HIGH (Rs.)
NSE784.35 -5.95 (-0.75 % )
PREV CLOSE(Rs.) 790.30
OPEN PRICE (Rs.) 790.30
BID PRICE (QTY) 784.35 (95 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 44058
TODAY'S LOW / HIGH(Rs.)
52 WK LOW / HIGH (Rs.)
Board Meetings
| Source Date | Board Meeting Date | Details |
|---|---|---|
| 13-May-2024 | 18-May-2024 | Final Dividend & Audited Results |
| 06-Feb-2024 | 12-Feb-2024 | Quarterly Results |
| 01-Nov-2023 | 07-Nov-2023 | Interim Dividend & Preferential Issue of shares & Issue Of Warrants & Quarterly Results |
| 25-Jul-2023 | 01-Aug-2023 | Quarterly Results |
| 26-Apr-2023 | 03-May-2023 | Third Interim Dividend & Audited Results |
| 20-Jan-2023 | 27-Jan-2023 | Second Interim Dividend & Quarterly Results |
| 18-Oct-2022 | 27-Oct-2022 | Quarterly Results |
| 28-Sep-2022 | 03-Oct-2022 | Inter alia, to consider and determine the issue price of Equity Shares to be issued under the QIP, including any discount on the floor price calculated in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the ?SEBI ICDR Regulations?) |
| 19-Jul-2022 | 25-Jul-2022 | Quarterly Results & First Interim Dividend |
| 19-May-2022 | 24-May-2022 | Preferential Issue of shares Inter alia, to discuss and consider, among other things, raising of funds either through issuance of equity shares, and or bonds including foreign currency convertible bonds I debentures/ non-convertible debt instruments along with warrants/ convertible debentures/ securities and/ or any other equity based instruments/ securities by way of qualified institutions placement or rights issue or preferential allotment, or through any other permissible mode or any combination thereof of any of the above, in accordance with the relevant provisions of applicable law and subject to approval of the Company's shareholders and receipt of applicable regulatory approvals |
